As guidelines to treat the risk factors of cardiovascular disease continue to evolve, Michael Weber, MD, explains how new editions of lipid, diabetes, and hypertension guidelines continue to improve patient care.
Dr Weber explains that we should not expect to see major changes as new treatment guidelines continue to develop, however, since last published several years ago, these guidelines are helpful because they are based on evidence, which is the basis to a good set of guidelines.
Dr Weber is confident in the decisions highlighted inside new guidelines by organized bodies such as the American Diabetes Association, National Kidney Foundation, and Joint National Committee because he feels that these bodies are putting a lot of effort into creating them.
Navigating Health Policy in an Election Year: Insights From Dr Dennis Scanlon
April 2nd 2024On this episode of Managed Care Cast, we're talking with Dennis Scanlon, PhD, the editor in chief of The American Journal of Accountable Care®, about prior authorization, price transparency, the impact of health policy on the upcoming election, and more.
Listen
The Biden administration recently launched the Global Health Security Strategy, a new effort to combat the spread of infectious diseases; lawmakers zeroed in on the risks of massive consolidation in health care during the first congressional hearing on the Change Healthcare hack; the FDA recently announced the recall of a pair of heart devices linked to numerous deaths and injuries.
Read More